# FDA Inspection 1276129 - Neotron S.p.A - February 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/neotron-spa/bd2f60d8-2223-45bf-9b2d-bc23179b878c
Source feed: FDA_Inspections

> FDA Inspection 1276129 for Neotron S.p.A on February 23, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276129
- Company Name: Neotron S.p.A
- Inspection Date: 2023-02-23
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1101319 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/neotron-spa/c144e741-6f86-4d70-9ee6-b5cc20653c3f)
- [FDA Inspection 1022356 - 2017-07-07](https://www.keypedia.com/records/fda_inspections/neotron-spa/4dd9cd0b-bade-4ea6-a792-d0a71ebd9cfe)

Company: https://www.keypedia.com/companies/neotron-spa/7e4ca124-0b66-41ba-8a9e-a1aecba08075

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c